More News

CellCentric’s first-in-class p300/CBP inhibitor drug CCS1477; capsule production complete ready...

Production of CCS1477 in capsule form is now complete, ahead of forthcoming first-in-human clinical...

read more

UK Innovation & Science Seed Fund Backs First Early-Stage Science...

First science companies funded from investment accelerator pilot that joins grant funding with venture...

read more